Relative Plasma Volume Monitoring for Identifying Volume-Sensitive and -Resistant Hypertension

Seminars in Dialysis

Volumn 23, Issue 5, 2010, Pages 462-465

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HEMATOCRIT; HUMAN; METABOLIC DISORDER; METABOLISM; PATHOPHYSIOLOGY; PLASMA VOLUME; RENAL REPLACEMENT THERAPY; RENOVASCULAR HYPERTENSION;

CARDIOVASCULAR DISEASES; HEMATOCRIT; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; PLASMA VOLUME; RENAL DIALYSIS; UREA; WATER-ELECTROLYTE IMBALANCE;

EID: 78049424087     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00742.x     Document Type: Article

References (18)

1. Agarwal R, Andersen MJ, Pratt JH: On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 3:153-158, 2008
2. Agarwal R: Hypertension and survival in chronic hemodialysis patients-Past lessons and future opportunities. Kidney Int 67:1-13, 2005
3. Li Z, Lacson Jr E, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW: The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48:606-615, 2006
4. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 53:500-507, 2009
5. Van der Sande FM, Kooman JP, Barendregt JN, Nieman FH, Leunissen KM: Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis. J Am Soc Nephrol 10:1303-1308, 1999
6. Leypoldt JK, Cheung AK, Steuer RR, Harris DH, Conis JM: Determination of circulating blood volume by continuously monitoring hematocrit during hemodialysis. J Am Soc Nephrol 6:214-219, 1995
7. Steuer RR, Bell DA, Barrett LL: Optical measurement of hematocrit and other biological constituents in renal therapy. Adv Ren Replace Ther 6:217-224, 1999
8. Steuer RR, Leypoldt JK, Cheung AK, Senekjian HO, Conis JM: Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. Am J Kidney Dis 27:525-532, 1996
9. Andrulli S, Colzani S, Mascia F, Lucchi L, Stipo L, Bigi MC, Crepaldi M, Redaelli B, Albertazzi A, Locatelli F: The role of blood volume reduction in the genesis of intradialytic hypotension. Am J Kidney Dis 40:1244-1254, 2002
10. Dasselaar JJ, Huisman RM, De Jong PE, Franssen CF: Measurement of relative blood volume changes during haemodialysis: merits and limitations. Nephrol Dial Transplant 20:2043-2049, 2005
11. Steuer RR, Germain MJ, Leypoldt JK, Cheung AK: Enhanced fluid removal guided by blood volume monitoring during chronic hemodialysis. Artif Organs 22:627-632, 1998
12. Lopot F, Kotyk P, Blaha J, Forejt J: Use of continuous blood volume monitoring to detect inadequately high dry weight. Int J Artif Organs 19:411-414, 1996
13. Sinha AD, Light RP, Agarwal R: Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight. Hypertension 55:305-311, 2010
14. Krapf R, Hulter HN: Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 4:470-480, 2009
15. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4:1925-1931, 2009
16. McIntyre CW: Effects of hemodialysis on cardiac function. Kidney Int 76:371-375, 2009
17. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24:1574-1579, 2009
18. Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 23:2965-2971, 2008